KDM1A and acute myeloid leukemia: GSK690, also known as GSK354, inhibits LSD1 (IC50 = 90 nM) with selectivity over other enzymes with AOD domains, and has shown effectiveness against AML with low cytotoxicity to animal cells [135,136,137].